Skip to content

Clinical study on the analgesic effect of transcutaneous electrical acupoint stimulation on the postoperative analgesic effect of IVF ovulation retrieval

Clinical study on the analgesic effect of transcutaneous electrical acupoint stimulation on the postoperative analgesic effect of IVF ovulation retrieval

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050153
Enrollment
Unknown
Registered
2021-08-19
Start date
2022-04-25
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

TEAS group:Transcutaneous Electrical Acupoint Stimulation treatment
Mock TEAS group:Mock Transcutaneous Electrical Acupoint Stimulation treatment

Sponsors

Chengdu University of TCM
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
21 Years to 42 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 21 to 42 years, infertility patients undergoing IVF treatment after oocyte retrieval; 2. Promoting ovulation with Gonadotropin Releasing Hormone Antagonist or Gonadotropin Releasing Hormone Agonist; 3. Intravenous anesthesia with drugs in oocyte retrieval; 4. Postoperative VAS-Pain Score >= 4; 5. Patients are conscious, able to complete the study and sign informed consent; 6. Not participating in other ongoing clinical studies.

Exclusion criteria

Exclusion criteria: 1. Patients with Chronic pain history; 2. History of long-term use of opioids, addiction to narcotic drugs, and alcohol abuse; 3. Neuropathy, mental illness or mental retardation do not correctly describe your feelings or understand visual analogue scale; 4. Allergy to the electrode, or scar, skin damage, infection, redness, swelling, violet and other manifestations at the measuring point or stimulation site; 5. Pacemaker or other implantable medical electronic devices; 6. Combined use of high frequency surgical equipment, artificial heart and lung, medical short wave, microwave therapeutic apparatus; 7. Patients with history of heart, brain, liver and kidney diseases.

Design outcomes

Primary

MeasureTime frame
VAS-Pain scores;

Secondary

MeasureTime frame
Pressure-pain Threshold;Pain Rating Index;Present Pain Intensity;VAS-Stress scores, VAS-Anxiety scores;Postoperative adverse symptoms;

Countries

China

Contacts

Public ContactYang Jie

Chengdu University of TCM

jenny_yang_jie@126.com+86 13882296714

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026